The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy
Abstract
Sympathetic and neural‐crest derived sensory neurons consisting of unmyelinated and small myelinated fibers are known to be affected at an early stage in diabetes mellitus (DM). Since these peripheral neurons need nerve growth factor (NGF) for their development and maintenance of function in adulthood, changes in endogenous NGF levels could be of relevance for the pathogenesis of diabetic neuropathy (DNP). Using an improved two‐site enzyme immunoassay for NGF, we have investigated whether endogenous NGF levels are altered in Sprague‐Dawley rats with DM induced by a single injection of streptozotocin (STZ). STZ‐treated rats are known to develop in many respects equivalents to neuropathic complications observed in human DM. We found in some sympathetically innervated target organs decreased NGF contents by maximally 56%: transiently in the iris 2 weeks and in the ventricle 12‐24 weeks after DM induction and permanently in the submandibular gland already 3 days after DM induction. Several weeks after onset of DM, NGF content was increased by maximally 145‐300% in most peripheral targets investigated, such as in iris, cardiac atrium and ventricle, spleen, prostate gland, and vas deferens. This is suggestive for an impaired NGF removal by NGF‐sensitive neurons in diabetic rats. Moreover, NGF levels were decreased to minimally 42.6 ± 4% of control in the NGF‐transporting sciatic nerve. NGF levels began to decrease not before 3 weeks after DM induction and remained decreased with 54.0 ± 5% of control even after 6 months duration of DM. About the same time (i.e., 2 weeks after induction of DM) NGF levels began to decrease in the superior cervical ganglion (where the sympathetic perikarya are located) to minimally 53.2 ± 4% of control 12 weeks after DM induction. No altered NGF levels were observed during a 3‐month duration of DM in the terminal ileum and sensory trigeminal ganglion. Since NGF exerts its neurotrophic action in the perikarya after its retrograde transport from the NGF‐producing periphery, our results are consistent with the hypothesis that an alteration in NGF levels may play a role in the pathogenesis of DNP as far as sympathetic neurons are concerned. Thus, our results suggest that DM influences the production and/or transport of endogenous NGF and consequently, that a deprivation of this neurotrophic factor may account for some of the functional deficits known to occur in DNP, such as impaired catecholaminergic transmitter synthesis. This hypothesis possibly opens the way for new concepts in the therapy of DNP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levi-Montalcini, R., & Angeletti, P. U. (1968) · Physiological Reviews · doi:10.1152/physrev.1968.48.3.534 · Cited by 2,016
Trophic factors and neuronal survival
Barde, Y.-A. (1989) · Neuron · doi:10.1016/0896-6273(89)90040-8 · Cited by 1,625
Physiology of nerve growth factor.
Thoenen, H., & Barde, Y. A. (1980) · Physiological Reviews · doi:10.1152/physrev.1980.60.4.1284 · Cited by 1,579
Heumann, R., Korsching, S., Bandtlow, C., & Thoenen, H. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.6.1623 · Cited by 1,022
The Nerve Growth Factor: Biochemistry, Synthesis, and Mechanism of Action
Greene, L. A., & Shooter, E. M. (1980) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.03.030180.002033 · Cited by 731
DRUGS PRODUCING DIABETES THROUGH DAMAGE OF THE INSULIN SECRETING CELLS
RERUP, C. C. (1970) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06885-1 · Cited by 728
Korsching, S., & Thoenen, H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.11.3513 · Cited by 557
Thoenen, H., Bandtlow, C., & Heumann, R. (1987) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/bfb0031026 · Cited by 550
(1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-4-579_1 · Cited by 525
Shelton, D. L., & Reichardt, L. F. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7951 · Cited by 513
Cited by
R�sen, P., Nawroth, P. P., King, G., M�ller, W., Tritschler, H.-J., & Packer, L. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.196 · Cited by 887
Diabetic neuropathy: Mechanisms to management
Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.005 · Cited by 790
Mechanism of diabetic neuropathy: Where are we now and where to go?
Yagihashi, S., Mizukami, H., & Sugimoto, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00070.x · Cited by 488
Nerve growth factor: from the early discoveries to the potential clinical use
Aloe, L., Rocco, M. L., Bianchi, P., & Manni, L. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-239 · Cited by 457
Neurons Undergo Apoptosis in Animal and Cell Culture Models of Diabetes
Russell, J. W., Sullivan, K. A., Windebank, A. J., Herrmann, D. N., & Feldman, E. L. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0254 · Cited by 411
Schmeichel, A. M., Schmelzer, J. D., & Low, P. A. (2003) · Diabetes · doi:10.2337/diabetes.52.1.165 · Cited by 367
Apfel, S. C. (2002) · International Review of Neurobiology · doi:10.1016/s0074-7742(02)50083-0 · Cited by 304
Diabetic cardiovascular autonomic neuropathy: Prognosis, diagnosis and treatment
Ziegler, D. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100403 · Cited by 291
Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy
Apfel, S. C., Kessler, J. A., Adornato, B. T., Litchy, W. J., Sanders, C., Rask, C. A., & The NGF Study Group* (1998) · Neurology · doi:10.1212/wnl.51.3.695 · Cited by 289
Diabetic neuropathy and oxidative stress
Pop-Busui, R., Sima, A., & Stevens, M. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.625 · Cited by 286
Nerve growth factor administration protects against experimental diabetic sensory neuropathy
Apfel, S. C., Arezzo, J. C., Brownlee, M., Federoff, H., & Kessler, J. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)90252-6 · Cited by 285
Reljanovic, M., Reichel, G., Rett, K., Lobisch, M., Schuette, K., Möller, W., Tritschler, H.-J., & Mehnert, H. (1999) · Free Radical Research · doi:10.1080/10715769900300721 · Cited by 283
Experimental diabetic neuropathy: an update
Sima, A. A. F., & Sugimoto, K. (1999) · Diabetologia · doi:10.1007/s001250051227 · Cited by 253
Effect of Streptozotocin‐Induced Diabetes on Rat Brain Mitochondria
Moreira, P. I., Santos, M. S., Moreno, A. M., Proença, T., Seiça, R., & Oliveira, C. R. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.1107.x · Cited by 47
Metadata
- Authors
- Hellweg, R., & Hartung, H. ‐.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 1990-06
- Volume
- 26
- Issue
- 2
- Pages
- 258-267
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2163813283
- Cited by
- 315
- References
- 42
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.